A few reasons why Riskpro should be your choice. Firstly, Risk Management is our only focus. Doing one thing every day makes us good at what we do. Secondly, our fees are very competitive and well below the larger consulting firms. We can use a dynamic pool of resources to ensure a cost-effective solution.
ESG needs to be adhered to both by large companies and smaller ones who supply to them or who export to the western economies where the government, investors as well as the general public is concerned about sustainability. Already companies have been asked by their buyer to give their compliance reports.
The manner of reporting, adherence to standards and avoidance of greenwashing is now an important thing and businesses need to start working towards their sustainability reporting. This webinar will cover ESG Reporting and how it needs to be approached.
The CANHEART ‘big data’ research initiative is aimed at measuring and improving cardiovascular health and the quality of ambulatory cardiovascular care provided in Ontario, Canada using the population-based CANHEART cohorts. The CANHEART cohorts were created through the linkage of 19+ routinely collected health administrative, vital statistics, survey and laboratory databases housed at ICES. The strength of these cohorts lies in the large sample size, containing information on 9.8 million Ontarians age 20-105 years, and diversity of the linked databases.
Building upon the insights gained to date through the CANHEART work, we have recently launched a new CANHEART SPOR project aimed at leveraging big data to conduct innovative cardiovascular clinical trials. We aim to: 1) undertake a pragmatic cluster randomized registry-based clinical trial to improve lipid-management amongst intermediate-and high-risk patients residing in high-risk health regions in Ontario (called CHOICES), and 2) develop novel algorithms for measuring clinical outcomes in clinical trials using health-related databases and compare whether they are as accurate as traditional event ascertainment methods in a prospective clinical trial (called INVESTED). These projects will be undertaken by an interdisciplinary team consisting of experts in administrative health databases, implementation science, clinical trials, knowledge translation and patient engagement.
EuSpRIG is a voluntary and non-profit organisation. Whatever your interest in Spreadsheet Risk Management, we would be pleased to hear from you and welcome any and every contribution.
Guided by the risk information-seeking and processing model, this study examines positive and negative affect separately in their influence on information-seeking intentions and avoidance through structural equation analyses. The highlight is that information avoidance seems to be driven by positive affect, while information seeking seems to be more heavily influenced by negative affect. Another interesting finding is that informational subjective norms are positively related to both seeking and avoidance, which suggests that one’s social environment has the potential to strongly influence the way he or she handles climate change information. Implications for theory and practice are discussed.
Researchers repeatedly discovered primary pharmaceutical contaminants, their metabolites, and transformation products in aquatic ecosystems. Body metabolism may not convert consumed pharmaceuticals to their metabolic elements before excretion. In this case, clinical and industrial wastes ensure their presence in the environment. Nevertheless, conventional wastewater treatment methods are ineffective for removing pharmaceutical wastes. Once in the ecosystem, they alter the physiological response of nontarget exposed aquatic and even terrestrial organisms due to induced toxicity.
IT involves the search for new opportunities through the introduction of new products into new markets. This kind of diversification strategy is one of the most risky and costly for company.
Five years ago, around Christmas 2012, I wrote an article about Cynefin, the sensemaking framework. I focused it on software development, because that was the main industry I worked in, and particularly focused on using it to work out which of our requirements were complex, so that we could embrace uncertainty and risk, and avoid…
If an organization really wants to empower its users, it needs a way to provide maximum power to the user with both safety and security. APIs allow you to design a solution that's not simply the average of these extremes, but rather provides 90% of the power with 99% of the security.
American Journal of Industrial and Business Management (AJIBM) is an international journal dedicated to publish high quality, original papers, and research developments in theories and applications in all areas of industrial and business management.
Open Journal of Preventive Medicine (OJPM) is an international journal dedicated to the latest advancement of Preventive Medicine. The goal of this journal is to provide a platform for scientists and academicians all over the world to promote, share, and discuss various new issues and developments in different areas of Preventive Medicine. All manuscripts must be prepared in English, and are subject to a rigorous and fair peer-review process. Accepted papers will immediately appear online followed by printed hard copy.
The consequences of the Japanese earthquake – especially the ongoing crisis at the Fukushima nuclear power plant – resonate grimly for observers of the American financial crash that precipitated the Great Recession. Both events provide stark lessons about risks, and about how badly markets and societies can manage them.
Zerstoerung der natuerlichen Lebensgrundlagen, Rechte nachfolgender Generationen, Kategorische Marktwirtschaft, Externalisierung von Umweltkosten, ökologische und soziale Schadenskosten, Internalisierung und Marktwirtschaft
The article presents the second of five modules that comprises the Part II of the Practice Certificate in Pharmacy Management which caters to pharmacists working in primary care organizations. It explores on the content domains of the task, the team, the individual, and the structures. It highlights risk management in businesses and organizations which aims to provide a thorough comprehension of the principles of risk management including risk assessment related to pharmacy business.
The number of swine flu cases is rising rapidly and experts are warning in the worst-case scenario 30% - or one in three of the UK population - could become infected and up to 65,000 people could die this winter. These sound like big, scary numbers, but what do they actually mean and how have they been calculated?
a self-regulating, unfiltered, non-hierarchical register, open to accredited researchers and analysists, of all apparent and competing risks to sustainability, where these can be backed up by evidence. Not a data-base in the simple sense, the main function is to allow authors to state, register and to promote any specific risk that they have identified in a summarised, common, accessible format, including proposed causal paths. The entry would link back to the authors own site or orginal papers.
In much of the world (but not in the U.S.,) drug-coated stents are avoided by cardiologists because of their high cost. To compensate for the inability to use these stents, many cardiologists outside of the U.S. have taken to administering sirolimus (also
In the Injury Theory, it's damage to the arterial endothelium, followed by platelet activation, then smooth muscle cell migration to injury, then macrophages, with resulting "foam cells." Engorged foam cells burst, starting the injury cycle all over again
it may no longer be enough to measure just HDL levels without determining levels of paroxonase and platelet-activating acetylhydrolase; levels of these enzymes may determine whether HDL is proinflammatory or protective. Likewise, measuring Lp(a) and small
Overweight men and women assigned to drink fructose-sweetened beverages as 25% of their energy intake developed atherogenic lipid profiles in just two weeks; unlike glucose, fructose promotedatherogenic lioproprotein phenotypes and glucose intolerance/ins
K. Wilson, and S. Hawken. Pharmacoepidemiology and drug safety, 22 (1):
108-10(January 2013)6932<br/>JID: 9208369; aheadofprint;<br/>Tipus d'estudis; Self controlled case series; Tamaño del efecto; Risc relatiu vs absolut.
G. Smith. Journal of epidemiology and community health, 60 (5):
382-8(May 2006)4828<m:linebreak></m:linebreak>JID: 7909766; 57-88-5 (Cholesterol); 9001-32-5 (Fibrinogen); ppublish;<m:linebreak></m:linebreak>Epidemiologia genètica.
M. Bobbio, B. Demichelis, and G. Giustetto. Lancet, 343 (8907):
1209-11(May 1994)6680<m:linebreak></m:linebreak>LR: 20071115; JID: 2985213R; OID: KIE: 43813; OTO: KIE; GN: KIE: KIE BoB Subject Heading: human experimentation/research design; GN: KIE: KIE BoB Subject Heading: patient care/drugs; GN: KIE: Full author name: Bobbio, Marco; GN: KIE: Full author name: Demichelis, Brunella; GN: KIE: Full author name: Giustetto, Guido; ppublish;<m:linebreak></m:linebreak>Presentació de dades.
K. Flegal, B. Graubard, and D. Williamson. American journal of epidemiology, 160 (4):
331-8(August 2004)4391<m:linebreak></m:linebreak>LR: 20041117; PUBM: Print; JID: 7910653; ppublish;<m:linebreak></m:linebreak>Risc atribuïble.
G. Siontis, and J. Ioannidis. International journal of epidemiology, 40 (5):
1292-307(October 2011)6416<m:linebreak></m:linebreak>JID: 7802871; 2011/07/06 aheadofprint; ppublish;<m:linebreak></m:linebreak>Tamaño del efecto; Interpretació de resultats.
H. Kim. Clinical cancer research : an official journal of the American Association for Cancer Research, 13 (2 Pt 1):
559-65(January 2007)4698<m:linebreak></m:linebreak>LR: 20071203; GR: AI 029530/AI/NIAID NIH HHS/United States; GR: HL 070149/HL/NHLBI NIH HHS/United States; JID: 9502500; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència; Competing risks.
P. Andersen, and N. Keiding. Statistics in medicine, 31 (11-12):
1074-88(May 2012)6439<m:linebreak></m:linebreak>CI: Copyright (c) 2011; JID: 8215016; aheadofprint;<m:linebreak></m:linebreak>Anàlisi de supervivència; Competing risks.
L. Mell, and J. Jeong. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28 (28):
4297-9(October 2010)Comparacions múltiples.